Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY Studies.
Atreya R, Ferrante M, Panaccione R, Feagan B, Shchukina O, Jairath V, Rieder F, Hisamatsu T, Siegmund B, Kligys K, Song A, Zambrano J, Mallick M, Zhang Y, Armuzzi A, D'Haens G. Atreya R, et al. Among authors: zambrano j. J Crohns Colitis. 2024 Nov 1:jjae164. doi: 10.1093/ecco-jcc/jjae164. Online ahead of print. J Crohns Colitis. 2024. PMID: 39485390
Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies.
Colombel JF, Schreiber S, D'Haens G, Rizzo J, Kligys K, Griffith J, Zambrano J, Zhou Q, Zhang Y, Kalabic J, Rieder F, Dubinsky MC, Panaccione R. Colombel JF, et al. Among authors: zambrano j. J Crohns Colitis. 2024 Jun 3;18(6):818-827. doi: 10.1093/ecco-jcc/jjad206. J Crohns Colitis. 2024. PMID: 38069472 Free PMC article. Clinical Trial.
Efficacy and safety of risankizumab by baseline corticosteroid use and achievement of corticosteroid-free clinical and endoscopic outcomes in patients with moderately to severely active Crohn's disease.
Schreiber S, Cross RK, Panaccione R, D'Haens G, Bossuyt P, Dotan I, Colombel JF, Louis E, Dubinsky MC, Kligys K, Neimark E, Song A, Zambrano J, Kalabic J, Cheng E, Zhang Y, Ferrante M. Schreiber S, et al. Among authors: zambrano j. Aliment Pharmacol Ther. 2024 Oct;60(7):897-906. doi: 10.1111/apt.18184. Epub 2024 Jul 25. Aliment Pharmacol Ther. 2024. PMID: 39054592 Clinical Trial.
Shorter Crohn's Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies.
Peyrin-Biroulet L, Colombel JF, Louis E, Ferrante M, Motoya S, Panaccione R, Torres J, Ungaro RC, Kligys K, Kalabic J, Zambrano J, Zhang Y, D'Haens G. Peyrin-Biroulet L, et al. Among authors: zambrano j. Gastro Hep Adv. 2024 Mar 7;3(4):539-550. doi: 10.1016/j.gastha.2024.02.008. eCollection 2024. Gastro Hep Adv. 2024. PMID: 39131711 Free PMC article.
Challenges and Opportunities in IBD Clinical Trial Design.
Dubinsky MC, Collins R, Abreu MT; International Organization for the Study of Inflammatory Bowel Diseases (IOIBD). Dubinsky MC, et al. Gastroenterology. 2021 Aug;161(2):400-404. doi: 10.1053/j.gastro.2021.03.065. Epub 2021 Apr 20. Gastroenterology. 2021. PMID: 33864796 Free article. No abstract available.
Genomic identification of expressed globulin storage proteins in oat.
Gil-González AB, Sjögren LLE, Bernfur K, Olsson O, Zambrano JA. Gil-González AB, et al. Among authors: zambrano ja. Front Plant Sci. 2024 Jul 23;15:1418658. doi: 10.3389/fpls.2024.1418658. eCollection 2024. Front Plant Sci. 2024. PMID: 39109060 Free PMC article.
Humoral Immunity across the SARS-CoV-2 Spike after Sputnik V (Gam-COVID-Vac) Vaccination.
Cornejo A, Franco C, Rodriguez-Nuñez M, García A, Belisario I, Mayora S, Garzaro DJ, Zambrano JL, Jaspe RC, Hidalgo M, Parra-Giménez N, Claro FE, Liprandi F, de Waard JH, Rangel HR, Pujol FH. Cornejo A, et al. Among authors: zambrano jl. Antibodies (Basel). 2024 May 11;13(2):41. doi: 10.3390/antib13020041. Antibodies (Basel). 2024. PMID: 38804309 Free PMC article.
Anaplasmosis outbreaks in taurine and zebu cattle in Brazil: causes, treatments, and Anaplasma marginale genetic diversity.
Leal LLLL, Cavalcante ASA, de Moraes IML, Salvador V, Couto LFM, Heller LM, Zapa DMB, Paula WVF, Sales KGDS, Lima E, Scarpa AB, de Lemos RAA, de Almeida Borges F, Zambrano J, Ferreira LL, da Silva Krawczak F, Dantas-Torres F, Lopes WDZ. Leal LLLL, et al. Among authors: zambrano j. Trop Anim Health Prod. 2024 May 10;56(4):154. doi: 10.1007/s11250-024-03957-5. Trop Anim Health Prod. 2024. PMID: 38727782
178 results